News

Support the Research Project on “Therapy Resistance in ALK-Positive Lung Cancer„

In most patients with ALK-positive lung cancer, modern targeted therapies initially work very well. ALK inhibitors specifically block the altered...
Read new

LuCE Atlas anouncement

Lung Cancer Europe Launches Groundbreaking Atlas to Address Unequal Access toTreatment Across Europe 12 April 2025 Too many people living...
Read new